Dong‐Ming Kuang

5.8k citations
48 papers · 4.0k indexed · 1 hit paper · h-index 29
Topics
Immune cells in cancer (25 papers)Cancer Immunotherapy and Biomarkers (20 papers)Immune Cell Function and Interaction (16 papers)

In The Last Decade

Dong‐Ming Kuang

45 papers receiving 3.9k citations

Hit Papers

Activated monocytes in peritumoral stroma of hepatocellul...20092026201420202009200400600

Peers

Dong‐Ming Kuang
Comparison fields: 5 of 89
  • Immunology 2.7k
  • Oncology 2.0k
  • Molecular Biology 943
  • Cancer Research 620
  • Hepatology 395
Replace Qiyi Zhao with:
Qiyi Zhao China
Linda Vatan United States
Magali Terme France
Shao‐Lai Zhou China
Mizuko Mamura Japan
Shuang‐Jian Qiu China
Yibei Zhu China
Su Yin Lim Australia
Tessa Fredriksen France
Dong‐Ming Kuang relative to Qiyi Zhao China Qiyi Zhao's profile →
Citations per field
00.5×1.5×1.8×
Qiyi Zhao · 1×
Citations per year

Countries citing papers authored by Dong‐Ming Kuang

Since Specialization
Citations

This map shows the geographic impact of Dong‐Ming Kuang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dong‐Ming Kuang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dong‐Ming Kuang more than expected).

Fields of papers citing papers by Dong‐Ming Kuang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dong‐Ming Kuang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dong‐Ming Kuang. The network helps show where Dong‐Ming Kuang may publish in the future.

Co-authorship network of co-authors of Dong‐Ming Kuang

This figure shows the co-authorship network connecting the top 25 collaborators of Dong‐Ming Kuang. A scholar is included among the top collaborators of Dong‐Ming Kuang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dong‐Ming Kuang. Dong‐Ming Kuang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 26
2 0
3 16
4 33
5 40
6 41
7 12
8 12
9 33
10 91
11 64
12 268
13 37
14 68
15 216
16 119
17 77
18 129
19 401
20 62

About Dong‐Ming Kuang

Dong‐Ming Kuang is a scholar working on Immunology, Oncology and Cancer Research, having authored 48 papers that have together received 4.0k indexed citations. Recurring topics across this work include Immune cells in cancer (25 papers), Cancer Immunotherapy and Biomarkers (20 papers) and Immune Cell Function and Interaction (16 papers). The work is most often cited by research in Immunology (2.7k citations), Oncology (2.0k citations) and Hepatology (395 citations). Dong‐Ming Kuang has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Limin Zheng, Qiyi Zhao, Yan Wu, Peng Chen, Changyou Wu, Xuefeng Li, Jing‐Ping Zhang, Jing Xu, Xiang‐Ming Lao and Wei Yuan. Their work appears in journals such as Cell, Journal of Clinical Investigation and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026